YGR114C Antibody

Shipped with Ice Packs
In Stock

Description

Overview of YGR114C Antibody

Target Protein:
YGR114C encodes a protein with UniProt accession P53268 in the S288c yeast strain . The antibody specifically binds to this protein, which plays roles in cellular processes such as transcriptional regulation and metabolic pathways, though its exact molecular function remains under investigation .

Commercial Availability:
Cusabio offers the YGR114C antibody (Product Code: CSB-PA345668XA01SVG) in two sizes (2ml/0.1ml) .

PropertyDetails
Target SpeciesSaccharomyces cerevisiae (strain ATCC 204508 / S288c)
ImmunogenRecombinant protein derived from YGR114C
ApplicationsWestern Blot (WB), Immunofluorescence (IF), ELISA
Host SpeciesNot specified (typically raised in rabbit or mouse)

Functional Studies

  • Genome-wide screens: SATAY (Saturated Transposition) studies identified YGR114C in genetic interaction networks linked to TORC1 signaling, suggesting involvement in nutrient sensing and growth regulation .

  • Post-translational modifications: The protein contains computationally predicted domains, including phosphorylation and ubiquitination sites, which are critical for studying regulatory mechanisms .

Antibody Validation

The YCharOS initiative underscores the importance of antibody validation using knockout (KO) controls. While the YGR114C antibody’s performance in specific assays (e.g., ChIP, WB) is not explicitly documented, recent studies highlight that ~50–75% of yeast proteins have at least one reliable commercial antibody . Recombinant antibodies, like those offered by Cusabio, generally show higher specificity compared to polyclonal alternatives .

Challenges in Antibody Characterization

While the YGR114C antibody is marketed for research, broader issues in antibody reliability persist:

  • Failure rates: ~12 publications per protein target include data from non-specific antibodies .

  • Vendor accountability: Cusabio and similar providers have removed ~20% of antibodies failing validation, emphasizing the need for rigorous testing .

Future Directions

  • Mechanistic studies: Clarify YGR114C’s role in TORC1 regulation using KO strains and antibody-based localization .

  • Proteome-scale validation: Expand initiatives like YCharOS to improve reproducibility in yeast research .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YGR114C; G6163; Putative uncharacterized protein YGR114C
Target Names
YGR114C
Uniprot No.

Target Background

Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is YGR114C and what experimental techniques are commonly used to study it?

YGR114C is a yeast gene that has been identified in multiple studies related to chromatin remodeling processes. Research indicates it may play functional roles in association with the SWR1 complex, which is involved in the ATP-dependent exchange of histone H2A for the histone variant Htz1 (H2A.Z in mammals) . Common experimental techniques used to study YGR114C include:

  • Chromatin Immunoprecipitation (ChIP) with anti-Htz1 antibodies

  • Real-time quantitative RT-PCR for expression analysis

  • Serial dilution growth assays to monitor phenotypes

  • Immunoprecipitation to study protein-protein interactions

These techniques allow researchers to determine the localization, expression, and functional relationships of YGR114C with other cellular components, particularly in relation to the SWR1 complex and ribosomal protein genes .

How can I confirm the functionality of tagged Arp6 and Swr1 proteins in YGR114C-related studies?

Confirming the functionality of tagged proteins is essential when studying YGR114C-related pathways. Based on established protocols, researchers should:

  • Monitor cell growth patterns using serial dilution assays

  • Test sensitivity to hydroxyurea (HU)

  • Compare growth at different temperatures (e.g., 30°C and 37°C)

A properly functioning tagged protein should demonstrate growth characteristics similar to wild-type strains. For example, five-fold serial dilutions of strains with tagged Arp6 and Swr1 can be plated on YPD with or without 50 mM HU and incubated at both 30°C and 37°C for 3 days . This approach allows researchers to verify that the tagging has not disrupted the normal function of these proteins in the biological pathways involving YGR114C.

What controls should be included when performing ChIP experiments with YGR114C antibodies?

Proper experimental controls are critical for reliable ChIP analysis using YGR114C antibodies:

Control TypePurposeImplementation
Input DNANormalizationReserve a portion of chromatin before immunoprecipitation
Negative ControlBackground assessmentUse non-specific IgG antibodies or untagged strains
Positive ControlAssay validationInclude known targets (e.g., GAL1, SWR1, RPL13A)
Wild-type ControlBaseline comparisonAlways run parallel experiments with wild-type strains
Deletion MutantSpecificity verificationInclude appropriate deletion strains (e.g., arp6Δ, swr1Δ)

Additionally, researchers should perform at least three independent experiments to ensure statistical reliability, as seen in studies where data points are presented as mean ± SD from multiple independent experiments .

How does Arp6 localization compare with Swr1 across chromosomes, and what implications does this have for YGR114C antibody-based research?

Comparative analysis of Arp6 and Swr1 localization patterns provides critical insights into their functional relationship and relevance to YGR114C research. Studies have mapped these proteins across chromosomes 3 and 4, revealing both overlapping and distinct binding patterns .

Importantly, in swr1 deletion mutants, Arp6-FLAG binding is still detected at certain genomic loci, confirming that Arp6 can associate with chromatin independently of the SWR1 complex . This has significant implications for experimental design, as researchers must carefully interpret data from YGR114C antibody studies in different genetic backgrounds.

What is the relationship between YGR114C, Htz1 incorporation, and gene expression in different genetic backgrounds?

The complex relationship between YGR114C and histone variant Htz1 incorporation affects gene expression patterns in various genetic backgrounds. ChIP analysis using anti-Htz1 antibodies has demonstrated that:

  • Htz1 associates with promoters of several genes including GAL1, SWR1, and ribosomal protein genes (RPL13A and RPS16B)

  • In arp6 and swr1 deletion mutants, Htz1 association is significantly reduced compared to wild-type cells, demonstrating the functional requirement of these proteins for proper Htz1 incorporation

  • This reduced Htz1 incorporation correlates with altered gene expression profiles as shown by quantitative RT-PCR analysis

Specific gene expression changes in arp6Δ and htz1Δ mutants have been quantified relative to ACT1 (used as a control), revealing differential regulation patterns. For example, RDS1 (YCR106W) and UBX3 (YDL091C) show altered expression in these mutants compared to wild-type cells . These findings highlight the importance of considering genetic background when interpreting YGR114C antibody experimental results.

How do nuclear pore complex interactions with YGR114C-associated genes change in response to carbon source and genetic perturbations?

The association between YGR114C-regulated genes and the nuclear pore complex (NPC) exhibits dynamic changes in response to both carbon source availability and genetic manipulations. ChIP analysis using antibodies against nuclear pore complex proteins (Mab414) has revealed:

  • The GAL1 gene, which is regulated by pathways involving YGR114C, shows differential association with the NPC depending on carbon source

  • In wild-type cells, the association pattern differs between glucose and galactose media conditions

  • In arp6 deletion mutants, this association pattern is significantly altered, suggesting Arp6 mediates proper gene-NPC interactions

These findings have important methodological implications for researchers using YGR114C antibodies:

  • Experimental design must account for growth conditions, as carbon source significantly impacts nuclear organization

  • NPC association studies require careful normalization, typically to wild-type cells on glucose media

  • Multiple independent experiments (at least three) are necessary for reliable quantification of these dynamic interactions

What approaches can be used to validate the specificity of YGR114C antibodies in different experimental contexts?

Validating antibody specificity is crucial for reliable YGR114C research. Researchers should employ multiple complementary approaches:

  • Genetic Validation: Compare immunoprecipitation results between wild-type and gene deletion strains (e.g., arp6Δ). Properly specific antibodies should show significantly reduced signal in deletion backgrounds .

  • Cross-Reactivity Testing: Perform Western blot analysis across multiple related proteins to ensure the antibody does not recognize similar epitopes on related proteins.

  • Correlation Analysis: Analyze the correlation between antibody binding patterns and known functional data. For example, the correlation coefficient (r) between Arp6 and Swr1 binding can be calculated across genomic regions (e.g., r=0.278, n=2001 for some datasets) .

  • Epitope Competition Assays: Use purified peptides containing the target epitope to compete for antibody binding, which should reduce specific signals.

  • Alternative Antibody Comparison: Where possible, compare results using antibodies raised against different epitopes of the same protein.

How should quantitative ChIP-PCR data for YGR114C be properly analyzed and normalized?

Proper analysis of quantitative ChIP-PCR data requires rigorous normalization and statistical treatment:

Normalization MethodApplicationAdvantages
Percent InputPrimary normalizationAccounts for chromatin input variations
Internal Control GeneSecondary normalizationCorrects for immunoprecipitation efficiency
Wild-Type BaselineRelative comparisonAllows comparison across experiments
Multiple Reference GenesEnhanced accuracyReduces bias from single reference gene

When analyzing ChIP data for YGR114C-related experiments:

  • Calculate the percentage of input DNA recovered by immunoprecipitation for each target sequence

  • Present data relative to a control condition (e.g., wild-type cells on glucose as 1.0)

  • Perform at least three independent experiments to calculate mean values and standard deviations

  • Apply appropriate statistical tests (e.g., t-test) to determine significance of differences (p<0.05)

  • Consider correlation analysis between binding patterns of different proteins to identify functional relationships

This methodological approach ensures that ChIP data accurately reflects the biological reality and allows for meaningful comparisons across different experimental conditions.

How can researchers address discrepancies between microarray and RT-PCR data when studying YGR114C-related gene expression?

Discrepancies between high-throughput (microarray) and targeted (RT-PCR) gene expression analyses are common in YGR114C research. To address these:

  • Validation Strategy: Verify key microarray findings with RT-PCR using multiple primer pairs targeting different regions of the transcript

  • Reference Gene Selection: Carefully select appropriate reference genes for RT-PCR normalization. While ACT1 is commonly used , it may not be stable under all conditions. Consider using multiple reference genes.

  • Expression Level Context: Interpret results based on expression magnitude:

    • For highly expressed genes (e.g., ribosomal protein genes), microarrays may saturate

    • For low-abundance transcripts, RT-PCR typically offers better sensitivity

  • Statistical Analysis: Calculate and report significance values and confidence intervals for both methods

  • Data Integration: Develop a decision tree for resolving conflicts:

    • If multiple RT-PCR experiments consistently contradict microarray results, prioritize RT-PCR

    • If discrepancy exists only for specific genes, investigate potential splice variants or cross-hybridization issues

The supplementary data available for YGR114C includes comprehensive microarray analyses in arp6Δ and swr1Δ cells (Table S2) , which provides a valuable baseline for expected expression changes.

What factors contribute to variability in YGR114C antibody ChIP experiments and how can they be minimized?

Multiple factors can introduce variability in ChIP experiments with YGR114C antibodies:

  • Chromatin Preparation Variability

    • Solution: Standardize cell growth conditions and crosslinking parameters

    • Evidence: Studies reporting ChIP data for YGR114C-related proteins consistently perform at least three independent experiments to account for this variability

  • Antibody Lot-to-Lot Variation

    • Solution: Purchase larger antibody lots for consistent long-term studies

    • Solution: Validate each new lot against previous standards

  • PCR Amplification Bias

    • Solution: Use multiple primer pairs per target region

    • Solution: Employ quantitative PCR with standard curves

  • Cell Cycle Heterogeneity

    • Solution: Synchronize cell populations when studying cell cycle-dependent processes

    • Evidence: YGR114C-related proteins show association with cell cycle regulators like CDC15

  • Growth Media Effects

    • Solution: Strictly control media composition and growth phase

    • Evidence: GAL1 gene association with nuclear pore complex shows significant differences between glucose and galactose media

To minimize these variables, researchers should implement rigorous standardization protocols and perform sufficient biological replicates (n≥3) as consistently demonstrated in published YGR114C research .

How might AI-based antibody generation technologies improve YGR114C antibody specificity and research applications?

Recent advances in AI-based antibody generation technologies, such as MAGE (Monoclonal Antibody GEnerator), could significantly enhance YGR114C antibody development and applications. MAGE represents a sequence-based protein Large Language Model fine-tuned for generating paired variable heavy and light chain antibody sequences against antigens of interest .

For YGR114C research, this approach offers several potential benefits:

  • Enhanced Specificity: AI models could design antibodies with optimized specificity for YGR114C, reducing cross-reactivity with related proteins

  • Epitope Targeting: Models could generate antibodies targeting specific domains or conformations of YGR114C-related proteins, allowing more precise functional studies

  • Reduced Development Time: Traditional antibody development against yeast proteins can be challenging and time-consuming; AI approaches could accelerate this process significantly

  • Antibody Diversification: Multiple antibody variants could be generated simultaneously, allowing researchers to select optimal candidates for specific applications

MAGE and similar AI approaches require only an antigen sequence as input, with no need for a preexisting antibody template . This capability could be particularly valuable for generating antibodies against poorly characterized regions of YGR114C or its interacting partners.

What are the implications of combining YGR114C antibody approaches with emerging single-cell technologies?

The integration of YGR114C antibody techniques with single-cell technologies represents a frontier in understanding cellular heterogeneity in yeast populations:

  • Single-Cell Resolution of Binding Patterns

    • Traditional ChIP experiments provide population averages of protein-DNA interactions

    • Single-cell approaches could reveal cell-to-cell variability in YGR114C-related protein localization

    • This could explain heterogeneous phenotypes observed in growth assays

  • Multi-Omics Integration

    • Correlating YGR114C antibody binding patterns with single-cell transcriptomics

    • Potential to identify direct vs. indirect regulatory relationships

    • Better understanding of how binding correlates with downstream effects on gene expression

  • Temporal Dynamics

    • Capturing dynamic changes in YGR114C-related protein localization during cellular processes

    • Real-time imaging of tagged proteins combined with antibody-based validation

    • Understanding rapid responses to environmental changes like carbon source shifts

  • Methodological Considerations

    • Adaptation of ChIP protocols for smaller cell numbers

    • Development of imaging-based approaches for spatial localization of YGR114C-related proteins

    • Computational methods to integrate binding data with other single-cell measurements

These approaches could provide unprecedented insights into the heterogeneity of YGR114C function across individual cells in a population, potentially revealing subpopulations with distinct regulatory mechanisms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.